Health

Results: 25-36 of 6663

Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments

ExQor Technologies Announces Advancement Toward Clinical Trials for Brain Regenerative Medicine Platform to Treat Alzheimer's Disease

PR Newswire associated0

AorticLab Receives FDA Approval to Initiate FLOWer™ Clinical Pivotal Investigation

PR Newswire associated0

Medtecs Showcases Global Capabilities at MEDICA and A+A in Germany

Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson's Disease and Movement Disorders® 2025

Medical iSight launches XRAIview for Apple Vision Pro

Business Wire embedded0

Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub

Eight Sleep Expands Its Sleep Technology Platform With New Pod Pillow Cover

Eight Sleep Expands Its Sleep Technology Platform With New Pod Pillow Cover

Blue Matter Hires New Partner, Eva Kersey, Further Strengthening Capabilities in Europe

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, announced today the successful acquisition of PKG Health, a leading innovator in movement disorder algorithms and digital endpoints for Parkinson’s disease.

Empatica Acquires PKG Health to Transform Parkinson’s Disease Monitoring

IDT’s partnership with Hamilton marks a global agreement to develop automation scripts for xGen™ and Archer™ NGS products from IDT for use on Hamilton’s Microlab® STAR™ and NIMBUS® liquid handling platforms. This provides labs worldwide with market-differentiated capabilities from IDT’s diverse NGS portfolio to identify key biomarkers critical for cancer research and other genomic applications.

Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery

Sepul Bio, an innovative business unit of Théa, Doses First Participant in Phase 3 HYPERION clinical trial of sepofarsen for CEP290-associated Leber Congenital Amaurosis Type 10